Evidence map›Paper›PMID 33600327›Full record

ArticleIEEE journal of biomedical and health informatics2021

Eliminating Indefiniteness of Clinical Spectrum for Better Screening COVID-19.

Guangyu Guo, Zhuoyan Liu, Shijie Zhao, Lei Guo, Tianming Liu

Abstract read
In one paragraph

Article in IEEE journal of biomedical and health informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guangyu Guo
Zhuoyan Liu
Shijie Zhao
Lei Guo
Tianming Liu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) has swept all over the world. Due to the limited detection facilities, especially in developing countries, a large number of suspected cases can only receive common clinical diagnosis rather than more effective detections like Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests or CT scans. This motivates us to develop a quick screening method via common clinical diagnosis results. However, the diagnostic items of different patients may vary greatly, and there is a huge variation in the dimension of the diagnosis data among different suspected patients, it is hard to process these indefinite dimension data via classical classification algorithms. To resolve this problem, we propose an Indefiniteness Elimination Network (IE-Net) to eliminate the influence of the varied dimensions and make predictions about the COVID-19 cases. The IE-Net is in an encoder-decoder framework fashion, and an indefiniteness elimination operation is proposed to transfer the indefinite dimension feature into a fixed dimension feature. Comprehensive experiments were conducted on the public available COVID-19 Clinical Spectrum dataset. Experimental results show that the proposed indefiniteness elimination operation greatly improves the classification performance, the IE-Net achieves 94.80% accuracy, 92.79% recall, 92.97% precision and 94.93% AUC for distinguishing COVID-19 cases from non-COVID-19 cases with only common clinical diagnose data. We further compared our methods with 3 classical classification algorithms: random forest, gradient boosting and multi-layer perceptron (MLP). To explore each clinical test item's specificity, we further analyzed the possible relationship between each clinical test item and COVID-19.

Indexed as

COVID-19 TestingNeural Networks, ComputerAlgorithmsArea Under CurveCOVID-19Databases, FactualHumansReproducibility of ResultsTime Factors

Identifiers

PMID33600327
PMCPMC8545172

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.